SIRT1 and melanoma: Thus, our data provide ample evidence that cryptolepine-induced inhibition of mTOR signaling and SIRT1 protein levels resulted in reduction of PGC-1α protein levels and mitochondrial biogenesis in cryptolepine-treated melanoma cells.